Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Rtw Biotech (RTW) Share Price

Price $1.21 on 01-04-2025 at 16:30:01
Change $0.00 0%
Buy $1.21
Sell $1.19
Buy / Sell RTW Shares
Last Trade: Buy 22.00 at $1.21
Day's Volume: 474,137
Last Close: $1.21
Open: $1.21
ISIN: GG00BKTRRM22
Day's Range $1.21 - $1.21
52wk Range: $1.19 - $1.73
Market Capitalisation: $405m
VWAP: $1.205436
Shares in Issue: 335m

Rtw Biotech (RTW) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 22 $1.21 Suspected BUY Trade
16:35:26 - 01-Apr-25
Sell* 1 $1.19 SI Trade
16:25:09 - 01-Apr-25
Unknown* 200,000 $1.205 Negotiated Trade
16:16:14 - 01-Apr-25
Buy* 377 $1.20899 Ordinary
16:10:30 - 01-Apr-25
Sell* 8 $1.20 SI Trade
15:43:19 - 01-Apr-25
Sell* 3 $1.20 SI Trade
15:43:19 - 01-Apr-25
Unknown* 731 $1.207942 Ordinary
Currency Conversion
15:33:57 - 01-Apr-25
Unknown* 5,322 $1.214926 Ordinary
Currency Conversion
15:21:51 - 01-Apr-25
Sell* 7,500 $1.205 Ordinary
14:38:56 - 01-Apr-25
Buy* 3,138 $1.21248 Ordinary
13:58:24 - 01-Apr-25
See more Rtw Biotech trades

Rtw Biotech (RTW) Share Price History

Time period:
to
Date Open High Low Close Volume
1st Apr 2025 (Tue) 1.21 1.21 1.21 1.21 474,137
31st Mar 2025 (Mon) 1.23 1.23 1.19 1.21 313,543
28th Mar 2025 (Fri) 1.22 1.22 1.21 1.21 75,782
27th Mar 2025 (Thu) 1.23 1.23 1.21 1.215 344,017
26th Mar 2025 (Wed) 1.25 1.25 1.23 1.235 245,497
25th Mar 2025 (Tue) 1.25 1.25 1.25 1.255 370,227
24th Mar 2025 (Mon) 1.24 1.25 1.24 1.25 51,221
21st Mar 2025 (Fri) 1.24 1.24 1.24 1.24 26,226
20th Mar 2025 (Thu) 1.26 1.26 1.25 1.26 254,408
19th Mar 2025 (Wed) 1.25 1.26 1.25 1.26 505,406
18th Mar 2025 (Tue) 1.25 1.26 1.24 1.245 215,093
17th Mar 2025 (Mon) 1.26 1.26 1.25 1.26 122,941
14th Mar 2025 (Fri) 1.25 1.28 1.25 1.26 146,472
13th Mar 2025 (Thu) 1.27 1.28 1.26 1.255 391,574
12th Mar 2025 (Wed) 1.28 1.29 1.26 1.265 222,101
11th Mar 2025 (Tue) 1.30 1.30 1.27 1.275 79,963
10th Mar 2025 (Mon) 1.31 1.33 1.31 1.33 89,610
7th Mar 2025 (Fri) 1.35 1.35 1.35 1.325 223,974
6th Mar 2025 (Thu) 1.32 1.32 1.32 1.32 257,754
5th Mar 2025 (Wed) 1.33 1.34 1.31 1.32 914,898
4th Mar 2025 (Tue) 1.34 1.34 1.33 1.335 40,587
3rd Mar 2025 (Mon) 1.35 1.35 1.35 1.35 70,374
See more Rtw Biotech price history

Rtw Biotech (RTW) Regulatory News

Date Source Headline
1st Apr 2025 7:00 am RNS Total Voting Rights
31st Mar 2025 7:00 am RNS Annual Financial Report
28th Mar 2025 7:00 am RNS Transaction in Own Shares
26th Mar 2025 7:00 am RNS Transaction in Own Shares
21st Mar 2025 7:00 am RNS Transaction in Own Shares
20th Mar 2025 7:00 am RNS Transaction in Own Shares
14th Mar 2025 7:01 am RNS Transaction in Own Shares
14th Mar 2025 7:00 am RNS Monthly Valuation Update and Factsheet
13th Mar 2025 7:00 am RNS Transaction in Own Shares
10th Mar 2025 7:00 am RNS Notice of Annual Results
See more Rtw Biotech regulatory news

Rtw Biotech (RTW) Share News

RTW Biotech underperforms benchmark but optimistic for 2025

31st Mar 2025 13:32

(Alliance News) - RTW Biotech Opportunities Ltd on Monday said it underperformed its benchmarks during 2024, while total net asset value climbed following the takeover of Arix Bioscience PLC. Read More

UK earnings, trading statements calendar - next 7 days

24th Mar 2025 16:14

Read More

RTW Biotech notes positive data in Kailera Therapeutics obesity trial

27th Jan 2025 10:15

(Alliance News) - RTW Biotech Opportunities Ltd on Monday said portfolio company Kailera Therapeutics has received positive results from a recent weight loss treatment trial. Read More

RTW Biotech participates in investment rounds worth USD300 million

17th Jan 2025 11:26

(Alliance News) - RTW Biotech Opportunities Ltd on Friday said it has made two separate investments as part of series A and C funding rounds in two clinical-stage firms. Read More

IN BRIEF: RTW Biotech makes further investment in Numab Therapeutics

14th Jan 2025 12:14

RTW Biotech Opportunities Ltd - investment fund managed by RTW Investments LP that specialises in the life sciences sector - Makes additional investment in Series C extension of Numab Therapeutics, a Swiss clinical stage biotech company focused on the development of multi-specific antibodies in immunology and oncology. Numab's CHF50 million, or USD54.5 million, extension, brought its total Series C funding to CHF180 million. Funds will be used to support its clinical development efforts. RTW Biotech first invested in Numab in May 2021. Read More

See more Rtw Biotech news
FTSE 100 Latest
Value8,634.80
Change51.99

Login to your account

Forgot Password?

Not Registered